RECURRENT PHYLLODES TUMOUR OF BREAST

Cite this:
[1]
D. S. H. G. M. Dr.Sinduja Munnamgi*, “RECURRENT PHYLLODES TUMOUR OF BREAST”, ijmhs, vol. 9, no. 5, pp. 447–451, May 2019.
© 2022 Interactive Protocols
RIGHTS & PERMISSIONS
Article Views
317
Altmetric
1
Citations
-
LEARN ABOUT THESE METRICS
   PDF  

Abstract

A 56-year-old post-menopausal female had presented with the complaints of huge lump in the right breast for one-year duration. The lump was insidious onset, progressive in size and was not associated with pain. There were no complaints of nipple discharge, skin changes. She was operated for excision of a lump in the right breast one and a half years ago and was proven to be a benign phyllodes tumor.

KEYWORDS:

 Special Issue

References

[1] Sanders LM, Daigle ME, Tortora M, et al. Transformation of benign fibroadenoma to malignant phyllodes tumor. Acta Radiol Open 2015;4:1–3. [2] De Roos WK, Kaye P, Dent DM. Factors leading to local recurrence or death after surgical resection of phyllodes tumours of the breast. British Journal of surgery. 1999 Mar;86(3):396-9. [3] Bernstein L, Deapen D, Ross RK. The descriptive epidemiology of malignantcystosarcoma phyllodes tumors of the breast. Cancer 1993;71:3020–4. [4] Bodnar TW, Acevedo MJ, Pietropaolo M. Management of non-islet-cell tumor hypoglycemia: a clinical review. J Clin Endocrinol Metab 2014;99:713–22. [5] Hino N, Nakagawa Y, Ikushima Y, et al. A case of a giant phyllodes tumor of the breast with hypoglycemia caused by highmolecular-weight insulin-like growth factor II. Breast Cancer 2010; 17:142–5. [6] Kataoka T, Haruta R, Goto T, et al. Malignant phyllodes tumor of the breast with hypoglycemia: report of a case. Jpn J Clin Oncol 1998;28:276–80. [7] Edwards T, Jaffer S, Szabo JR, et al. Cellular fibroadenoma on Core needle biopsy: management recommendations for the radiologist. Clin Imaging 2016;40:587–90. [8] Noguchi S, Yokouchi H, Aihara T, et al. Progression of fibroadenoma to phyllodes tumor demonstrated by clonal analysis. Cancer 1995;76:1779–85. [9] Tan BY, Acs G, Apple SK, et al. Phyllodes tumours of the breast: a consensus review. Histopathology 2016;68:5–21. [10] Yoon CS, Kim KN. Selective salvage of zones 2 and 4 in the pedicled TRAM flap: a focus on reducing fat necrosis and improving aesthetic outcomes. Springerplus 2016;5:68–74. [11] Ng CC, Tan J, Ong CK, et al. MED12 is frequently mutated in breast phyllodes tumours: a study of 112 cases. J Clin Pathol 2015;68:685–91.

Article Metrics Graph

Chart Graph | Range Graph

Content

Section

References

[1] Sanders LM, Daigle ME, Tortora M, et al. Transformation of benign fibroadenoma to malignant phyllodes tumor. Acta Radiol Open 2015;4:1–3.
[2] De Roos WK, Kaye P, Dent DM. Factors leading to local recurrence or death after surgical resection of phyllodes tumours of the breast. British Journal of surgery. 1999 Mar;86(3):396-9.
[3] Bernstein L, Deapen D, Ross RK. The descriptive epidemiology of malignantcystosarcoma phyllodes tumors of the breast. Cancer 1993;71:3020–4.
[4] Bodnar TW, Acevedo MJ, Pietropaolo M. Management of non-islet-cell tumor hypoglycemia: a clinical review. J Clin Endocrinol Metab 2014;99:713–22.
[5] Hino N, Nakagawa Y, Ikushima Y, et al. A case of a giant phyllodes tumor of the breast with hypoglycemia caused by highmolecular-weight insulin-like growth factor II. Breast Cancer 2010; 17:142–5.
[6] Kataoka T, Haruta R, Goto T, et al. Malignant phyllodes tumor of the breast with hypoglycemia: report of a case. Jpn J Clin Oncol 1998;28:276–80.
[7] Edwards T, Jaffer S, Szabo JR, et al. Cellular fibroadenoma on Core needle biopsy:
management recommendations for the radiologist. Clin Imaging 2016;40:587–90.
[8] Noguchi S, Yokouchi H, Aihara T, et al. Progression of fibroadenoma to phyllodes tumor demonstrated by clonal analysis. Cancer 1995;76:1779–85.
[9] Tan BY, Acs G, Apple SK, et al. Phyllodes tumours of the breast: a consensus review. Histopathology 2016;68:5–21.
[10] Yoon CS, Kim KN. Selective salvage of zones 2 and 4 in the pedicled TRAM flap: a focus on reducing fat necrosis and improving aesthetic outcomes. Springerplus 2016;5:68–74.
[11] Ng CC, Tan J, Ong CK, et al. MED12 is frequently mutated in breast phyllodes tumours: a study of 112 cases. J Clin Pathol 2015;68:685–91.

Source

License

All paper submissions must carry the following duly signed by all the authors:
“I certify that I have participated sufficiently in the conception and design of this work and the analysis of the data (wherever applicable), as well as the writing of the manuscript, to take public responsibility for it. I believe the manuscript represents valid work. I have reviewed the final version of the manuscript and approve it for publication. Neither has the manuscript nor one with substantially similar content under my authorship been published nor is being considered for publication elsewhere, except as described in an attachment. Furthermore I attest that I shall produce the data upon which the manuscript is based for examination by the editors or their assignees, if requested.”